Hjem › Spiserørkreft › North Carolina › Durham
Kliniske studier for Spiserørkreft i Durham, NC
10 studier for Spiserørkreft søker deltakere på steder i og rundt Durham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi unna
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Durham VA Medical Center, Durham
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
RekruttererFase 2
- Duke University Medical Center, Durham
DESTINY-PANTUMOUR04
RekruttererObservasjonsstudie
- Research Site, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruttererFase 1
- Duke University Medical Center, Durham
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
RekruttererFase 2
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi unna
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservasjonsstudie
- UNC- Chapel Hill, Chapel Hill · 10 mi unna
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi unna
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekruttererFase 1
- Duke Cancer Institute /ID# 276267, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi unna
Spiserørkreft-studier i andre byer
- Houston, TX36 studier
- Boston, MA23 studier
- New York City, NY22 studier
- Nashville, TN19 studier
- St. Louis, MO17 studier
- Pittsburgh, PA15 studier
- Los Angeles, CA15 studier
- Baldwin Park, CA14 studier
- Grand Rapids, MI14 studier
- Philadelphia, PA13 studier
- San Antonio, TX12 studier
- Rochester, MN11 studier
Andre studier i Durham
- Brystkreft64 studier
- Kreft (alle typer)58 studier
- Ikke-småcellet lungekreft39 studier
- Multipelt myelom37 studier
- Akut myelogen leukemi33 studier
- Metastatisk kreft33 studier
- Prostatakreft32 studier
- Lungekreft32 studier
- Kolorektal kreft28 studier
- Eggstokkreft27 studier
- Kronisk lymfatisk leukemi27 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.